Clinical Trial Update: Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completed Phase 1/2 clinical trial evaluating mesenchymal stem/stromal cell therapy for frailty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frailty

Drugs mentioned

• Mesenchymal stem/stromal cell therapy (mesenchymal stem/stromal cells)

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Frailty | Phase 1, Phase 2 | Status: COMPLETED